Clearer Night Vision

Clinical studies for all indications submitted to the FDA showed higher participant satisfaction with night vision after the Advanced CustomVue procedure than before with glasses or contact lenses.

Treat With Certainty™

A new level of precision may be predictably achieved by linking the advanced refractive information of the WaveScan WaveFront™ System with the STAR S4 IR™ Excimer Laser System, providing accurate alignment and centration for every patient.

• Fourier technology captures approximately 240 data points (over a 7 mm pupil) — 25-times more precise than standard measurements for glasses or contact lenses
• The Fourier algorithm delivers the highest resolution of the wavefront error available today by utilizing 100% of the available data to design the optimal treatment
• Iris Registration (IR) uses multiple matching reference points from the iris to capture and compensate for torsional angle, as well as pupil centroid shift
• IR provides greater alignment accuracy with sub-flap iris imaging
• IR also allows for instant re-registration in the event of intraoperative cyclotorsional movement

Variable Spot Scanning (VSS™) And Variable Repetition Rate (VRR™) Technologies

VSS technology, available only from AMO, ensures the intricate shapes reconstructed by the Fourier wavefront algorithm are precisely ablated. VRR technology delivers proprietary algorithms that vary the laser's pulse rate. By continually changing the size and placement of the beam, VRR technology provides:

• The ability to deliver Fourier shapes with optimized ablation time while ensuring minimal thermal impact on the cornea
• More accurate reconstruction of the wavefront profile and intricate ablation shapes
• Faster treatment times
• Smoother ablation profiles

Combined, VSS and VRR technologies:

• Minimize thermal effects and optimize clinical results
• Achieve the ideal treatment speed by mixing the pulse sizes, distribution and repetition rate
• Provide potentially better overall outcomes, including night vision quality

Monovision Treatment For Presbyopic Myopia Patients

The Advanced CustomVue procedure is the first and only FDA-approved wavefront-guided monovision treatment to correct both near and distance vision in presbyopic patients with low-to-moderate myopia, with or without astigmatism.

At 12 months:

• 99% of study participants achieved binocular near UCVA of 20/25 or better
• 97% achieved binocular distance UCVA of 20/25 or better
• 86% of study participants achieved 20/20 or better for both uncorrected near and uncorrected distance visual acuity
• 98% of study participants expressed satisfaction with their results

*As determined by the Market Scope 2007 Annual Refractive Surgeon Survey.